Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Craving beliefs comparison among patients receiving buprenorphine, methadone, or opium tincture maintenance
IRCT2017011724066N2Phase 3Completed
- Sponsor
- Torbat-e Heydarieh University of Medical Sciences
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of buprenorphine, methadone and opium tincture in opioid use disorder (OUD) and substance use disorder (SUD) (3 arms), sponsored by Torbat-e Heydarieh University of Medical Sciences. Primary endpoint: Craving beliefs. Started Jan 2017; status: completed.
02
Drugs
buprenorphinemethadoneopium tincture
03
Conditions
opioid use disorder (OUD)substance use disorder (SUD)
Beyond the preview
Go deeper on IRCT2017011724066N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017011724066N2.